Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells

Area of Science:

• Bone biology
• Endocrinology
• Cellular mechanisms

Background:

• Estrogen is vital for skeletal homeostasis and bone remodeling.
• Estrogen modulates receptor activator of NF-κB ligand (RANKL) expression, a key factor in bone resorption.
• The precise cellular mechanisms of estrogen's action on bone remain debated.

Purpose of the Study:

• To elucidate the cellular mechanisms by which estrogen regulates bone resorption.
• To identify the specific cell types mediating estrogen's effects on RANKL expression.
• To investigate the role of estrogen receptor-alpha (ERα) in these processes.

Main Methods:

• Utilized murine reconstitution models for selective gene deletion or inhibition.
• Investigated estrogen receptor-alpha (ERα) and RANKL in hematopoietic versus mesenchymal cells.
• Employed in situ expression profiling in bone cells.

Main Results:

• Identified bone lining cells as critical gatekeepers of estrogen-controlled bone resorption.
• Demonstrated that estrogen deficiency leads to increased bone resorption primarily due to reduced ERα-mediated suppression of RANKL in bone lining cells.
• Highlighted the specific role of ERα in bone lining cells for regulating RANKL.

Conclusions:

• Bone lining cells are crucial mediators of estrogen's effects on skeletal homeostasis.
• Lack of ERα signaling in bone lining cells drives increased bone resorption in estrogen deficiency.
• Targeting ERα in bone lining cells may offer therapeutic strategies for bone loss.